Erweiterte Suche

Herr Philippe Brassac ist stellvertretender Vorsitzender und Chief Executive Officer bei Crdit Agricole SA, bei Sacam International SAS, bei Caisse Rgionale Crdit Agricole Mutuel Provence Cte d'Azur, Generalsekretär bei Fdration Nationale du Crdit Agricole, bei Gecam GIE und Vorsitzender bei SACAM Dveloppement SAS und bei Sofipaca Gestion SAS sowie Mitglied bei Confdration Nationale de la Mutualit, de la Coopration Et. Er ist Mitglied des Verwaltungsrats von Crdit Agricole SA, Crdit Lyonnais SA, Federation Rgionale du Crdit Agricole Mutuel du Centre, Sacam Participations SAS, Scicam Ltd, Rue la Botie SAS, Adicam SARL und Fondation du Crdit Agricole Pays de France. Herr Brassac war zuvor als Chairman & Chief Executive Officer bei Deltager beschäftigt. Außerdem war er im Vorstand der Cassa di Risparmio di Parma e Piacenza SpA und der Crdit Foncier de Monaco. Er erwarb einen Bachelor-Abschluss an der Ecole Nationale de la Statistique & de l'Administration und einen Master-Abschluss an der Universit Paris Dauphine.

Philippe Collombel is currently a Director at iDbyMe SA and TVTY SA, a General Partner at Partech Partners SAS, and a Member-Supervisory Board at October SA. He previously held Director positions at Cartesis SA, Cartesis Ltd., Total Immersion SA, and wazap AG, and was a Partner at Accenture Plc.
He also served as a Member-Supervisory Board at Unibail-Rodamco-Westfield SE from 2017 to 2020 and is currently a Member-Supervisory Board at Unibail-Rodamco-Westfield NV.
Mr. Collombel received a graduate degree from Université Paris 1 Panthéon-Sorbonne, an undergraduate degree from Sciences Po in 1984, and an MBA from Kellogg School of Management in 2000.

Philippe Leboulch is the founder of Fujirebio Europe NV, founded in 1950, and bluebird bio, Inc., founded in 1992.
At bluebird bio, Inc., he held the title of Chief Scientific Officer in 2010.
Currently, he is the Director at Institut National de la Santé & de la Recherche Médicale.
Previously, he worked as a Principal at SAB Industries Ltd.
Dr. Leboulch earned a doctorate degree from the University of Paris Jussieu.

Philippe Chauveau is the founder and had founded SCYNEXIS, Inc. in 2000, where he held the title of Chairman.
He also held the position of Chairman at Apple (UK) Ltd.
Mr. Chauveau's former jobs include Vice President-Research & Development at Bell Laboratories and Independent Director at EDAP TMS SA, where he held the title of Independent Director in 2020.
Mr. Chauveau received his undergraduate degree from Trinity College Dublin.